Outset Medical Inc
NASDAQ:OM

  • LAST PRICE
    0.7134
  • TODAY'S CHANGE (%)
    0.0234 (3.3913%)
  • Bid / Lots
    0.7097/ 3
  • Ask / Lots
    0.7170/ 8
  • Open / Previous Close
    0.6884 / 0.6900
  • Day Range
    0.6637
    0.7525
  • 52 Week Range
    0.5750
    14.5950
  • Volume
    3,582,201

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
OM
Outset Medical Inc
35.9M
-0.2x
---
HBIO
Harvard Bioscience Inc
127.3M
-11.5x
---
VRAYQ
ViewRay Inc
180.0
0.0x
---
XYLO
Xylo Technologies Ltd
2.7M
-0.1x
---
FONR
Fonar Corp
114.7M
11.5x
-15.67%
AKYA
Akoya Biosciences Inc
119.3M
-1.9x
---
As of 2024-08-22

Company Information

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Contact Information

Headquarters
3052 Orchard DriveSAN JOSE, CA, United States 95134
Phone
971-563-3083
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Leslie Trigg
Chief Financial Officer
Nabeel Ahmed
Senior Vice President - Operations and R&D
Marc Nash
General Counsel, Company Secretary
John Brottem
Lead Independent Director
D. Keith Grossman

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$35.9M
Revenue (TTM)
$116.4M
Shares Outstanding
52.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.95
EPS
$-3.14
Book Value
$2.44
P/E Ratio
-0.2x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-129.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.